Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression...
Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Introduction
Metabolomics has emerged as a powerful method to provide insight into cancer progression, including separating patients into low- and high-risk groups for overall (OS) and progression-free survival (PFS). However, survival prediction based mainly on metabolites obtained from biofluids remains elusive.
Objectives
This proof-of-...
Alternative Titles
Full title
Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9724684
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9724684
Other Identifiers
ISSN
1573-3890,1573-3882
E-ISSN
1573-3890
DOI
10.1007/s11306-022-01891-x
